Nationwide trends in diagnosed sedative, hypnotic or anxiolytic use disorders in adolescents and young adults enrolled in Medicaid: 2001–2019
Sedative, hypnotic or anxiolytic use disorders (SHA-UD) diagnoses increased 3- to 5-fold between 2001 and 2019 for adolescent and young adult US Medicaid enrollees, with prevalence remaining low in adolescents. The increase over two decades may be attributed to changes in the availability, use and misuse of sedative, hypnotic and anxiolytic medications and to increased detection, awareness and diagnosing of SHA-UD.
Authors
- Deborah S. Hasin (ORCID: https://orcid.org/0000-0002-6533-7021)
- Mark Olfson (ORCID: https://orcid.org/0000-0002-3958-5662)
- Greta Bushnell (ORCID: https://orcid.org/0000-0002-4056-8405)
- Tobias Gerhard (ORCID: https://orcid.org/0000-0002-8598-5771)
- Kristen Lloyd (ORCID: https://orcid.org/0000-0001-8057-1003)
- Magdalena Cerdá (ORCID: https://orcid.org/0000-0001-8441-7046)
- Katherine M. Keyes
Institutions
- Rutgers, The State University of New Jersey (US)
- Columbia University Irving Medical Center (US)
- New York University (US)
- Columbia University (US)
Publication Details
- Journal
- Addiction
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1111/add.16749
- Citations
- 6
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.33
Funders
- Sanofi
- National Institute on Drug Abuse